Anzeige
Mehr »
Montag, 07.09.2026 - Börsentäglich über 12.000 News
Explorer vor nächstem Schritt: Kupfer sichtbar
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CSAQ | ISIN: GB00BK80TJ35 | Ticker-Symbol:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PHYSITRACK PLC Chart 1 Jahr
5-Tage-Chart
PHYSITRACK PLC 5-Tage-Chart
ACCESS Newswire
178 Leser
Artikel bewerten:
(0)

Physitrack PLC: Physitrack Wins Deal with Large US Healthcare System Following Competitive Process

Three-year enterprise agreement with a total contract value of approximately US$390,000 (approximately EUR 336,000) in total, subject to signing of the software services agreement.

LONDON, GB / ACCESS Newswire / September 7, 2026 / New York City, September 7, 2026

Physitrack PLC (Nasdaq First North Premier Growth Market:PTRK), a global provider of digital health and wellbeing technology, today announces that it has been selected as the preferred digital rehabilitation technology by a large US academic healthcare system following a competitive selection process.

The customer has confirmed that Physitrack's commercial proposal, of approximately US$390,000 in total, is in line with its expectations. The parties have now entered the software services agreement review and contracting phase.

The proposed commercial terms cover a three-year relationship with a break option after the second year. This would represent approximately US$260,000 (approximately EUR 224,000) in committed revenue across the first two years and a potential total contract value of approximately US$390,000 over the full three-year period.

The selection follows a competitive process against established vendors and further strengthens Physitrack's position within the US enterprise healthcare market.

Subject to completion of the software services agreement, Physitrack will provide its digital rehabilitation technology to support the healthcare system's practitioners and patients. The solution will enable the customer to:

  • Deliver high-quality, digitally supported home exercise programmes

  • Provide patients with convenient access to prescribed exercises and educational content

  • Capture measurable patient outcomes to inform clinical decision-making

Implementation will follow the customer's clinical systems integration timetable, with go-live expected in late 2027. Revenue will be recognised from go-live and phased across the contract term, commencing in the financial year ending 31 December 2027.

Henrik Molin, CEO and Founder of Physitrack PLC, commented:

"We are delighted to announce, on Labor Day 2026, that we have been selected following a competitive process by one of the United States' leading academic healthcare systems. This deal represents an important reference win in our priority market, a great achievement by our New York sales team, and reflects the strength of our technology, clinical content and ability to operate within complex healthcare environments.

We look forward to completing the contracting process and building a long-term partnership with the customer, supporting its teams as the solution is implemented across its clinical services."

About Physitrack

Physitrack plc (Nasdaq First North:PTRK), d/b/a Physitrack Group, is a global digital health and wellness SaaS delivering personalized, scalable remote care through its Physitrack and Champion Health platforms.
Physitrack enables healthcare providers to deliver and manage app-guided physical and occupational rehabilitation with measurable patient outcomes and built-in billing and reimbursement support, while Champion Health provides businesses with mental, physical, and financial wellbeing solutions to support workforce health and productivity.

Physitrack Group's solutions seamlessly integrate with existing systems, including EMR/EHR/PMS connectivity, and are trusted by more than 80,000 providers and organizations across 180+ countries. For more information, visit www.physitrackgroup.com and follow us on LinkedIn and X.

Enquiries regarding this announcement should be addressed to:

Corporate Contact:
Henrik Molin, CEO and co-founder, Physitrack
ir@physitrack.com
media@physitrack.com

Investor and Media Contact:
Investor Relations
Jonathan@harbor-access.com
Tel +1 475 477 9401

Attachments

Physitrack Wins Deal with Large US Healthcare System Following Competitive Process

SOURCE: Physitrack PLC



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/physitrack-wins-deal-with-large-us-healthcare-system-following-co-1217529

© 2026 ACCESS Newswire
KI braucht Strom
Halbleiter, Speicherchips und Rechenzentren haben Anlegern im KI-Boom bereits enorme Gewinne beschert. Doch jetzt zeichnet sich mit der benötigten Energie der nächste große Flaschenhals ab. Neue KI-Rechenzentren benötigen nicht mehr einige Megawatt, sondern zum Teil mehrere Gigawatt Leistung – so viel wie mehrere moderne Kernkraftwerksblöcke.

Damit beginnt ein weltweites Wettrennen um verfügbare Stromkapazitäten. Hyperscaler sichern sich bereits über langfristige Verträge gewaltige Energiemengen, während Stromnetze und Erzeugungskapazitäten mit dem Ausbau kaum Schritt halten können. Zusätzlich verschärfen geopolitische Risiken rund um den Iran-Krieg und die Straße von Hormus die Situation.

Für Energieversorger und ihre Zulieferer könnte damit ein goldenes Zeitalter beginnen. Steigende Nachfrage, langfristige Abnahmeverträge und wachsende Strompreise schaffen ein Umfeld, in dem ausgewählte Unternehmen zum nächsten großen KI-Trade werden könnten.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die besonders stark vom explodierenden Energiehunger der KI profitieren könnten – und bei Anlegern bislang teilweise noch unter dem Radar laufen.

Jetzt den kostenlosen Report sichern – und die nächsten Gewinner des KI-Booms entdecken!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.